Related Experiment Videos
National collaborative: Top five drugs reported as causing harm through medication error in pediatrics.
Marg Colquhoun1, Elaine Orrbine, Ian Sheppard
1Institute for Safe Medication Practices Canada. mcolquhoun@ismp-canada.org
Dynamics (Pembroke, Ont.)
|January 22, 2010
Summary
Pediatric medication errors harm children, with specific drugs identified as high-risk. Collaborative initiatives between the Canadian Association of Paediatric Health Centres (CAPHC) and ISMP Canada aim to improve pediatric patient safety.
Area of Science:
- Pediatric Patient Safety
- Medication Error Analysis
- Healthcare Quality Improvement
Background:
- Medication errors pose a significant risk in pediatric care.
- The Canadian Association of Paediatric Health Centres (CAPHC) and the Institute for Safe Medication Practices Canada (ISMP Canada) are key organizations in this field.
- Previous data on pediatric medication incidents is crucial for identifying trends.
Purpose of the Study:
- To analyze medication incidents in pediatric patients.
- To identify the top drugs causing harm due to medication errors.
- To inform critical care practitioners about patient safety initiatives.
Main Methods:
- Analysis of over 4,000 medication incidents submitted by 11 CAPHC member organizations.
- Data collected by ISMP Canada between October 2005 and June 2008.
- Identification of drugs and contributing factors in incidents resulting in harm.
Main Results:
- Over 4,000 pediatric medication incidents were analyzed.
- 305 incidents were reported to have resulted in patient harm.
- The study identified the top five drugs associated with harm and common contributing factors.
Conclusions:
- Medication errors in pediatric settings require ongoing attention and targeted interventions.
- Collaborative efforts between healthcare organizations are vital for enhancing pediatric patient safety.
- Understanding specific drug risks and error factors can guide safety improvements.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...